MedPath

Biomarkers in Idiopathic Juvenile Arthritis

Not Applicable
Conditions
Idiopathic Juvenile Arthritis
Interventions
Other: blood sample for identifying biomarkers
Registration Number
NCT02343770
Lead Sponsor
University Hospital, Montpellier
Brief Summary

Juvenile idiopathic arthritis (JIA) is the most common form of arthritis in children. The etiology is unknown. Several types of arthritis fall under the JIA heading. Oligoarticular JIA with antinuclear antibodies affects about half of all children. There 's no specific markers. Our purpose is to identify new markers in this pathology. The ProtoArray®Human Protein Microarray allows rapid and efficient detection of protein interaction using a suitable protein or small molecule probe. The investigators hope so detect novel potential autoantigen biomarkers specific in JIA.

Detailed Description

We select 10 patients with inclusion criteria and 10 controls. We analyse their blood sample (5ml). The ProtoArray® Microarray allows to detect novel protein-protein interactions, to rapidly perform serum profiling using a sensitive method to detect potential autoantigen biomarkers. The ProtoArray® Human Protein Microarray is a high-density protein microarray containing thousands of purified human proteins for protein interaction screening.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
idiopathic juvenile arthritisblood sample for identifying biomarkersblood sample
controlblood sample for identifying biomarkersblood sample
Primary Outcome Measures
NameTimeMethod
identification of specific autoantigen biomarkers1 day

Identify blood sampling biomarkers of juvenile idiopathic arthritis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cardiology paediatric consultation, Arnaud de Villeneuve Hospital

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath